Second Regular Session S.B. 1283
COMMITTEE ON HEALTH AND HUMAN SERVICES
SENATE AMENDMENTS TO S.B. 1283
(Reference to printed bill)
Page 1, line 5, after "use" insert "; annual user satisfaction survey; report"
Page 2, line 17, strike "January" insert "July"
Line 22, after the period insert "The medical practitioner may be granted a six‑month waiver from the requirement in this subsection due to technological limitations that are not reasonably within the control of the practitioner or other exceptional circumstances demonstrated by the practitioner, pursuant to a process established by board rule.
I."; strike “CHECK” insert “OBTAIN A PATIENT UTILIZATION REPORT FROM”
Reletter to conform
Line 23, strike "this"; after "subsection" insert "H of this section"
Line 26, strike "or" insert a comma
Line 27, after "condition" insert "or dialysis treatment"
Line 30, after "facility" insert ", assisted living facility, correctional facility"
Lines 32 and 33, strike "is licensed pursuant to title 32, chapter 11 and"
Line 34, strike "five days" insert "a five-day period"; strike "oral"
Between lines 34 and 35, insert:
"6. The medical practitioner is prescribing no more than a five-day prescription and has reviewed the program's central database tracking system for that patient within the last thirty days, and the system shows that no other prescriber has prescribed a controlled substance in the preceding thirty‑day period.
7. The prescription is a substitute for an initial prescription to which the patient had an adverse reaction and the patient has turned over all remaining doses of the previous prescription to the prescriber or dispenser for disposal.
Page 3, line 14, after “system” insert “pursuant to a process established by board rule”
After line 14, insert:
"N. The board shall conduct an annual voluntary survey of program users to assess user satisfaction with the program's central database tracking system. The survey may be conducted electronically. On or before December 1 of each year, the board shall provide a report of the survey results to the president of the senate, the speaker of the house of representatives and the governor and shall provide a copy of this report to the secretary of state.
O. This section does not prohibit a medical practitioner regulatory board from obtaining and using information from the program's central database tracking system.
Sec. 2. Section 36-2608, Arizona Revised Statutes, is amended to read:
36-2608. Reporting requirements; waiver; exceptions
A. If a medical practitioner dispenses a controlled substance listed in section 36‑2513, 36‑2514 or 36‑2515, or if a prescription for a controlled substance listed in any of those sections is dispensed by a pharmacy in this state, a health care facility in this state for outpatient use or a board‑permitted nonresident pharmacy for delivery to a person residing in this state, the medical practitioner, health care facility or pharmacy must report the following information as applicable and as prescribed by the board by rule:
1. The name, address, telephone number, prescription number and drug enforcement administration controlled substance registration number of the dispenser.
2. The name, address and date of birth of the person or, if for an animal, the owner of the animal for whom the prescription is written.
3. The name, address, telephone number and drug enforcement administration controlled substance registration number of the prescribing medical practitioner.
4. The name, strength, quantity, dosage and national drug code number of the schedule II, III or IV controlled substance dispensed.
5. The date the prescription was dispensed.
6. The number of refills, if any, authorized by the medical practitioner.
B. Except as provided in subsection D of this section, a dispenser must use the September 28, 2011 version 4, release 2 standard implementation guide for prescription monitoring programs published by the American society for automation in pharmacy or any subsequent version or release of that guide to report the required information.
C. The board shall allow the reporter to transmit the required information by electronic data transfer if feasible or, if not feasible, on reporting forms as prescribed by the board. The board shall not require the reporter to submit the required information more frequently than once each day.
D. A dispenser who does not have an automated record keeping recordkeeping system capable of producing an electronic report in the established format may request a waiver from electronic reporting by submitting a written request to the board. The board shall grant the request if the dispenser agrees in writing to report the data by submitting a completed universal claim form as prescribed by the board by rule.
E. The board by rule may prescribe the prescription form to be used in prescribing a schedule II, III or IV controlled substance if the board determines that this would facilitate the reporting requirements of this section.
F. The reporting requirements of this section do not apply to the following:
1. A controlled substance administered directly to a patient.
2. A controlled substance dispensed by a medical practitioner at a health care facility licensed by this state if the quantity dispensed is limited to an amount adequate to treat the patient for a maximum of seventy‑two hours with not more than two seventy-two hour cycles within any fifteen-day period.
3. A controlled substance sample.
4. The wholesale distribution of a schedule II, III or IV controlled substance. For the purposes of this paragraph, "wholesale distribution" has the same meaning prescribed in section 32‑1981.
5. A facility that is registered by the drug enforcement administration as a narcotic treatment program and that is subject to the record keeping recordkeeping provisions of 21 Code of Federal Regulations section 1304.24."
Amend title to conform